Lisata Therapeutics Ownership | Who Owns Lisata Therapeutics?

Overview RevenueFinancials Chart Transcripts

Lisata Therapeutics Ownership Summary

Lisata Therapeutics is owned by 11.96% institutional investors, 26.24% insiders, and 61.80% retail investors. Vanguard group is the largest institutional shareholder, holding 3.10% of LSTA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.10% of its assets in Lisata Therapeutics shares.

LSTA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lisata Therapeutics	11.96%	26.24%	61.80%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	270.91K	3.10%	$503.89K
Deltec asset management	90.00K	1.04%	$450.90K
Rangeley capital	75.00K	0.86%	$375.75K
Geode capital management	70.89K	0.82%	$355.21K
Css llc/il	61.90K	0.71%	$310.11K
Blackrock funding, inc. /de	54.86K	0.63%	$274.83K
Virtu financial	42.21K	0.49%	$211.00K
Vanguard fiduciary trust	34.92K	0.40%	$174.93K
Gts securities	31.40K	0.36%	$157.29K
State street	25.35K	0.29%	$126.99K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rangeley capital	75.00K	0.37%	$375.75K
Deltec asset management	90.00K	0.08%	$450.90K
Css llc/il	61.90K	0.01%	$310.11K
Sol capital management	12.18K	0.01%	$29.34K
Jbf capital	13.23K	0.01%	$66.30K
Virtu financial	42.21K	0.01%	$211.00K
Gts securities	31.40K	0.01%	$157.29K
Connective capital management	1.02K	0.00%	$5.09K
Founders capital management	1.67K	0.00%	$8.35K
International assets investment management	5.00K	0.00%	$25.05K

Top Buyers

Holder	Shares	% Assets	Change
Deltec asset management	90.00K	0.08%	90.00K
Rangeley capital	75.00K	0.37%	75.00K
Css llc/il	61.90K	0.01%	61.90K
Virtu financial	42.21K	0.01%	42.21K
Vanguard fiduciary trust	34.92K	-	34.92K

Top Sellers

Holder	Shares	% Assets	Change
Renaissance	-	-	-131.72K
Bml capital management	-	-	-73.35K
Penderfund capital management	-	-	-47.50K
Ground swell capital	-	-	-38.99K
Dimensional fund advisors lp	-	-	-14.25K

New Positions

Holder	Shares	% Assets	Change	Value
Deltec asset management	90.00K	0.08%	90.00K	$450.90K
Rangeley capital	75.00K	0.37%	75.00K	$375.75K
Css llc/il	61.90K	0.01%	61.90K	$310.11K
Virtu financial	42.21K	0.01%	42.21K	$211.00K
Vanguard fiduciary trust	34.92K	-	34.92K	$174.93K

Sold Out

Holder	Change
Citigroup	-1.00
Wells fargo & company/mn	-1.00
Loring wolcott & coolidge fiduciary advisors llp/ma	-2.00
Barclays	-4.00
Raymond james financial	-6.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	30	-11.76%	1,089,429	3.00%	11	8.67%	12	-36.84%	4	33.33%
Mar 31, 2026	14	-44.00%	441,823	-38.21%	5	7.59%	8	-38.46%	-	-100.00%
Dec 31, 2025	18	-18.18%	684,695	-9.09%	7	10.23%	8	-20.00%	6	50.00%
Sep 30, 2025	21	5.00%	752,137	-3.88%	8	10.57%	9	12.50%	4	33.33%
Jun 30, 2025	20	-9.09%	782,490	-0.11%	9	10.96%	8	-20.00%	3	-40.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	191.37K	2.10%	-
Vanguard Morn Total Stk Mkt Idx Investor	191.37K	2.10%	-
Vanguard MStar Total Stk Mkt Idx Invest	191.37K	2.10%	-
Vanguard Institutional Extnd Mkt Idx Tr	80.44K	0.88%	-
Fidelity Extended Market Index	38.27K	0.42%	-728.00
Pender Alternative Arbitrage Plus F	17.00K	0.19%	-10.00K
Spartan Extended Market Index Pool F	10.50K	0.12%	56.00
Fidelity Series Total Market Index	10.37K	0.11%	-
NT Ext Equity Mkt Index Fund - NL	8.26K	0.09%	5.27K
NT Ext Equity Mkt Idx Fd - L	7.14K	0.08%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 08, 2021	MYERS STEVEN S	-	Buy	$30.19K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q3	-	-

LSTA Ownership FAQ

Who Owns Lisata Therapeutics?

Lisata Therapeutics shareholders are primarily institutional investors at 11.96%, followed by 26.24% insiders and 61.80% retail investors. The average institutional ownership in Lisata Therapeutics's industry, Biotech Stocks , is 379.61%, which Lisata Therapeutics falls below.

Who owns the most shares of Lisata Therapeutics?

Lisata Therapeutics’s largest shareholders are Vanguard group (270.91K shares, 3.10%), Deltec asset management (90K shares, 1.04%), and Rangeley capital (75K shares, 0.86%). Together, they hold 5.00% of Lisata Therapeutics’s total shares outstanding.

Does Blackrock own Lisata Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Lisata Therapeutics.

Who is Lisata Therapeutics’s biggest shareholder by percentage of total assets invested?

Rangeley capital is Lisata Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.37% of its assets in 75K Lisata Therapeutics shares, valued at 375.75K$.

Who is the top mutual fund holder of Lisata Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lisata Therapeutics shares, with 2.10% of its total shares outstanding invested in 191.37K Lisata Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools